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Background: In adults, low circulating interleukin 10 (IL10) has been associated with obesity and type 2 diabetes.
However, studies investigating IL10 in overweight and obese children have yielded conflicting results. The aim of
this study was to investigate factors associated with serum IL10 concentration in young Chinese adolescents.
Methods: Young adolescents (n=325) ages 13.33±1.10 years were recruited into the cross-sectional study from
2010 to 2011. Parameters of obesity, individual components of MetS, iron status and serum IL10 were evaluated.
Results: Compared with their normal weight counterparts, overweight adolescents had lower serum IL10 but
higher TNFα, nitric oxide (NO) and IL1β concentrations (all p<0.05). Obese adolescents had increased IL1β but
decreased hepcidin concentration compared with normal weight (p<0.01 and p<0.05; respectively). A strong
inverse relationship (p<0.0001) was found between IL10 and pro-inflammatory cytokines (TNFα and IL1β).
Multivariate linear regression analysis showed serum IL1β was significantly correlated with IL10 (β=−0.156,
p<0.0001). When overweight and obese adolescents were assessed separately from normal weight, only IL1β was
inversely associated with serum IL10 (β=−0.231, p=0.0009). The association between IL10 and IL1β was weaker in
adolescents with normal weight (β=−0.157, p=0.0002), after adjusting for gender, TNFα, IFNγ and NO.
Conclusions: Our study confirmed that low IL10 concentration is associated with overweight and obesity in young
adolescents. We also demonstrated for the first time that pro-inflammatory cytokine IL1β is independently
associated with IL10. A decline in IL10 concentration in overweight and obese adolescents may further contribute
to the IL1β-mediated inflammatory environment associated with obesity.
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Interleukin 10 (IL10) plays a central role in regulating
immune response and limiting inflammation. IL10 sup-
presses inflammation through various mechanisms in-
cluding inhibition of the synthesis of pro-inflammatory
cytokines such as IL12 and TNFα via suppression of p65
NF-kB and c-rel activity in macrophages [1]. IL-10 is
also important in down-regulation of the release of re-
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reproduction in any medium, provided the orregulation of antigen presentation capacity and immune
tolerance [2]; and suppression of proliferative and cyto-
toxic T cell responses [3].
There is growing evidence linking IL10 to obesity [4],
metabolic syndrome (MetS) and cardiovascular disease
[5]. In adults, low circulating IL10 has been associated
with obesity [6], cardiovascular disease [7-9] and type 2
diabetes [5,10-12]. Clinical significance of circulating
IL10 concentrations have been demonstrated in acute
coronary syndrome [8,9] and insulin resistance [5,10-12].
The balance of pro-and anti-inflammatory cytokines is
an important determinant of atherosclerotic plaque in-
stability. IL10 expression has been found within human
atherosclerotic plaques [13]. Smith et al. studied 95Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and observed significantly lower serum IL10 concentra-
tions in patients with unstable angina compared with
those with stable angina [9]. Heeeschen et al. investi-
gated the prognostic impact of C-reactive protein (CRP)
and IL10 in patients with acute coronary syndrome and
reported elevated IL10 concentrations were strongly
associated with prognosis of acute coronary syndromes
[8]. The predictive value of IL10 was independent
of myocardial necrosis but significantly interacted
with CRP concentration, suggesting the importance of
the balance between pro-inflammatory and anti-
inflammatory cytokines as a major determinant of pa-
tient’s outcome in acute coronary syndromes [8].
IL10 also plays a protective role against the develop-
ment of insulin resistance. Plasma IL10 concentrations
were positively correlated with insulin sensitivity in
young healthy adults (r=0.37, p=0.00023) [11]. Forte
et al. performed the grade-of-membership analysis in
490 type 2 diabetic and 349 control subjects of Italian
Caucasians [14]. The authors reported 74.4% of subjects
negative for IL-10 -824 T allele were diabetic patients
characterized by vascular damages, suggesting that IL10
-597A/-824 T/-1087A negative subjects are more prone
to the major type 2 diabetic vascular damages [14].
Studies investigating IL10 in children and young
adolescents with obesity have yielded conflicting results
[15-18]. According to a study by Gozal and colleagues,
obese children with obstructive sleep apnea had low
plasma IL10 concentration [17]. In a study including 70
severely obese and 30 normal weight children aged 11.46
±3.42 years old, Calcaterra and colleagues reported that
serum IL10 concentrations were higher in severely obese
children compared to normal weight [16]. Tam et al.
reported no differences in IL10 concentration between
normal and overweight children at 8 years old; however,
at 15 years old, serum IL10 was elevated in overweight
and obese girls when compared to normal weight girls
of same age [18]. These data suggest that effects of obes-
ity on IL10 serum concentration vary with age, sex and
obesity-related complications. Additionally, the possible
association between IL10 and iron status has also been
highlighted in some studies. For instance, patients re-
ceiving high doses of IL10 developed hyperferritinemia
[19] whereas iron supplementation in IL10- knock out
mouse increased pro-inflammatory cytokine production
in high iron diet group compared with chow diet [20].
In adults, IL10 plays a protective role against the de-
velopment of obesity-related declines in health. How-
ever, the effect of obesity on IL10 concentration in
children is not clear. We therefore measured IL10
concentration and investigated the factors associated
with IL10 homeostasis in young adolescents. The
variables analyzed included: 1) anthropometry; 2)individual components of metabolic syndrome; 3) pro-
inflammatory and oxidative stress markers; and 4) iron
parameters.
Methods
Study design and participants
This cross-sectional study involved young adolescents
from 2 junior high schools located in Taipei and New
Taipei City, Taiwan. From September 2010 to November
2011, 340 subjects (ages 13.33±1.10 years, 182 boys and
158 girls) were enrolled in the study. Exclusion criteria
were as follows: individuals with missing data for clin-
ical biochemistry and anthropometry (n=14) and individ-
uals with abnormal serum ferritin concentration
(>500 ng/ml) (n=1). A total of 325 adolescents were in-
cluded in the analysis. Informed parental consent was
obtained for enrollment into the study. The study was
approved by the Research Ethics Committee of Taipei
Medical University (201204011).
Data collection
Data was collected from the subjects by the same med-
ical staff from the Taipei Medical University Hospital
using the same methods and tools. Children were ad-
vised not to drink or eat after midnight or exercise
24 hours prior to data collection. On the morning of the
study, fasted children who were free of medical condi-
tions were admitted to the school-based health center.
Body weight, height, waist circumference,% body fat and
blood pressure measurements were obtained by standard
methods as described elsewhere [21]. Waist circumfer-
ence was measured at the midpoint between the lower
edge of the rib cage and the top of the iliac crest [22].
Age-sex specific cut off point for body mass index (BMI)
was used to define overweight and obesity in adolescent
according to guidelines of the Department of Health in
Taiwan [23,24]. BMI was calculated as mass (Kg)/[height
(m)]2. Subjects with BMI greater than 85th percentile of
age-sex-specific value were grouped as overweight while
those with BMI greater than 95th percentile were classi-
fied as obese. Percentage of body fat was estimated by
bioelectrical impedance method (Omron Body Fat
Analyzer HBF-306).
Metabolic syndrome (MetS) was defined based on the
modified International Diabetes Federation (IDF) criteria
for 10-<16 years old children and adolescents [25]. Indi-
viduals with the presence of ≧3 criteria listed below were
classified as MetS: (1) waist circumference: ≥90 cm for
boys and ≥80 cm for girls; (2) triglyceride (TG):
≥150 mg/dL; (3) fasting plasma glucose (FPG): ≥100 mg/
dL; (4) high density lipoprotein cholesterol (HDL):
<40 mg/dL for boys and < 50 mg/dL for girls; and (5)
systolic blood pressure (SBP)≥130 mmHg or diastolic
blood pressure (DBP)≥85 mmHg.
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Fasting blood samples were collected in vacuum tubes
containing either EDTA or lithium heparin. All blood sam-
ples were separated into red blood cells and serum and
stored at −80°C until analysis. Total cholesterol (TC), LDL,
HDL and TG were determined by an autoanalyzer (Hitachi
737, USA). Fasting plasma glucose concentration was
detected using a glucose oxidase method (YSI 203 glucose
analyzer, Yellow Springs Instruments, Yellow Springs, OH).
Serum ferritin was measured using a commercially available
electrochemiluminescence immunoassay and was quanti-
tated by the Roche Modular P800. Serum iron and total iron
binding capacity (TIBC) were measured by ferrozine-based
colorimetric method. Percentage transferrin saturation (%
TS) was calculated by serum iron/TIBC × 100%. Serum
hepcidin was assessed by an enzyme-linked immunosorbent
assay (DRG International Inc; Marburg). The assay dynamic
range is between 2.5 ng/ml-140 ng/ml. Definitions of abnor-
mal biochemistry blood lipid, glucose profiles [26] and iron
status [27] are described elsewhere. Cytokines concentra-
tions (IL1β, TNFα, IL10, IFNγ) were determined by
Enzyme-Linked Immunosorbent Assay kit (Procarta Cyto-
kine Assay Kit; Affymetrix, Inc., USA) according to the man-
ufacturer’s instructions. Nitric oxide (NO) concentration in
the serum was determined by Griess reagent system. The
coefficients of variation (CV) for normal weight and over-
weight/obese adolescents were: IL1β (36.1% v.s. 36.4%),
TNFα (41.2% v.s. 48.9%), IL10 (26.9% v.s. 28.9%), IFNγ
(36.4% v.s 30.8%) and NO (89.5% v.s. 86.3%).
Statistical analyses
Statistical analyses were performed using the Statistical
Analysis Systems software (SAS version 9.22; SAS Insti-
tute, Inc). Normally distributed data were presented as
means ± standard error of mean (SEM). Differences be-
tween groups were analyzed by the unpaired t-test. Chi-
square or Fisher's Exact Test were used for comparison
of proportions. Variables not normally distributed were
natural log-transformed to achieve a normal distribution
but untransformed values were used for reporting re-
sults. The association between serum IL10 concentration
and clinical and blood biochemistry parameters were
assessed using Pearson’s correlation coefficient. A multi-
variate linear regression model was used to examine the
relationship between the dependent variable (serum
IL10) and potential variables. The P value was p<0.05
except for the analysis in Table 1 where a value of




A total of 325 children were entered in this study. 231
children were classified as normal body weight while 94children were diagnosed as overweight or obese. Table 2
shows clinical and biochemical characteristics of study
subjects according to nutritional status. The prevalence
of overweight was 13.5% (19.67% for boys and 18.30%
for girls) and obesity was 15.4% (23.77% for boys and
19.26% for girls). Children with high triglyceride concen-
tration were 5.5% (4.0% for boys and 7.3% for girls) while
21.5% had low HDL (7.43% for boys and 38% for girls).
About 12% of children had elevated fasting glucose con-
centration (15.4% for boys and 8% for girls). Only one
male adolescent had fasting plasma glucose concentra-
tion >126 mg/dl. Five girls were diagnosed with MetS,
which was 1.58% of all the subjects.
Altered cytokine profiles in overweight and obese
adolescents
Compared with their normal weight counterparts, over-
weight adolescents had lower serum IL10 but higher
TNFα, NO and IL1β concentrations (all p<0.05; Table 2).
Obese adolescents had increased IL1β but decreased
hepcidin concentration compared with the respective
concentration in normal weight adolescents (p<0.01 and
p<0.05; respectively). There were no differences in circu-
lating IFNγ between the two groups. No sex differences
were found in cytokine profiles except IL1β. Over-
weight/obese boys and girls had significantly higher
serum IL1β concentration compared with respective
normal weight boys and girls (boys: 1.19±0.05 v.s.
1.0±0.03 pg/ml; p<0.05; girls: 1.17±0.06 v.s. 0.94
±0.03 pg/ml; p<0.01) (data not shown).
We grouped the individuals according to the IL10 con-
centration to investigate the potential confounding vari-
ables that are associated with IL10 concentration. The
clinical characteristics of the study adolescents in rela-
tion to tertile groups of IL10 are shown in Table 1. An
inverse correlation was found between BMI and IL10
tertiles but it did not reach statistical significance
(Table 1). Furthermore, no correlation was found be-
tween IL10 terriles and the individual components of
metabolic syndrome. IL10 tertiles were positively corre-
lated with transferrin saturation (p=0.0167) and serum
hepcidin (p<0.0001) but inversely correlated with serum
total iron binding capacity (TIBC) (p=0.011). Pro-
inflammatory cytokines such as TNFα, IL1β and NO
were inversely correlated with IL10 tertiles (all
p<0.0001).
Significant correlation between pro-inflammatory
cytokines and IL10 concentration
We next performed correlation analysis to identify the
possible variables that were associated with IL10.
Pearson’s correlations between log serum IL10 and se-
lected laboratory parameters are shown in Table 3. After
adjusting for gender, IL10 was inversely correlated with
Table 1 Clinical and biochemical characteristics of young adolescents according to IL10 tertiles (n=325, boys=175 and
girls=150)
Variables# T1* T2* T3* P-trend
BMI (kg/m2) 20.97 ±4.3 20.65± 4.3 19.99 ±3.2 0.0740
Body fat (%) 22.64 ±8.7 21.95± 7.6 20.78 ±6.78 0.0818
Waist circumference (cm) 71.21 ±11.9 70.55± 10.8 69.16 ±9.9 0.1788
Fasting glucose (mg/dL) 90.99 ±8.67 91.81± 6.07 92.25 ±7.79 0.2240
Fasting serum insulin (μIU/ml) 16.95 ±14.2 16.87± 10.3 17.22 ±15.8 0.8848
HOMA-IR 3.98 ±4.0 3.88± 2.5 4.05 ±4.2 0.8940
Sytolic BP (mmHg) 110.89 ±11.0 112.33± 8.9 110.75 ±8.5 0.9094
Diastolic BP (mmHg) 62.88 ±8.2 63.80± 8.7 63.41 ±7.7 0.6371
HDL cholesterol (mg/dL) 54.06 ±12.3 56.31± 13.4 56.59 ±12.67 0.1481
LDL- cholesterol (mg/dL) 89.44 ±27.0 91.64± 21.2 90.73 ±24.2 0.6998
Triglyceride ((mg/dL)) 76.53 ±35.6 70.85± 31.2 78.23 ±49.6 0.7537
Total cholesterol (mg/dL) 159.9 ±30.2 159.63± 24.2 160.75 ±30.1 0.8420
Serum iron (ug/dL) 87 ±35.8 86.52± 33.1 95.32 ±36.0 0.0833
Serum TIBC (ug/dL) 352.1 ±44.6 348.56± 47.2 337.01 ±37.2 0.0114
Serum ferritin (ng/ml) 57.87 ±36.1 55.22± 37.0 55.92 ±32.0 0.6844
Transferrin Saturation (%) 25.17 ±10.7 25.14± 9.6 28.63 ±11.1 0.0167
Hepcidin (ng/ml) § 422.46 ±418.7 554.71± 446.7 698.92 ±420.7 <0.0001
TNFα (pg/ml) § 24.56 ±11.2 18.96± 7.3 18.81 ±6.7 <0.0001
IFNγ (pg/ml) 6.72 ±1.7 6.34± 2.3 6.24 ±2.5 0.1148
NO (uM) § 9.31 ±4.3 7.10± 4.2 6.69 ±4.3 <0.0001
IL1β (pg/ml) § 1.26 ±0.4 1.00± 0.4 0.86 ±0.2 <0.0001
*IL10 cut-off point: Tertile 1: <8.03 pg/ml, Tertile 2>=8.03 pg/ml <=10.6 pg/ml, Tertile 3>10.6 pg/ml.
#Data are presented as means±standard error of mean (SEM) and percent for continuous and categorical variables respectively.
§Bonferroni correction p<0.0023.
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related with log-transferrin saturation (r=0.131; p=0.018)
and log-hepcidin (r=0.271; p<0.0001). Furthermore,
strong inverse correlations were found between IL10
and IL1β (r=−0.328, P<0.0001), IL10 and TNFα
(r=−0.209, P=0.0001), IL10 and NO (r=−0.28668,
P<0.0001), and between IL10 and IFNγ (r=−0.139,
P=0.012) (Table 3). We next separated overweight and
obese adolescents from normal weight. All cytokines in-
vestigated continued to have strong inverse correlations
with IL10 in normal weight adolescents [IFNγ
(r=−0.253), TNFα (r=−0.1773), IL1β (r=−0.347), NO
(r=−0.311); all p<0.0001]. However, only IL1β was sig-
nificantly correlated with IL10 in overweight and obese
adolescents (r=−0.376, P<0.0001) (data not shown).
IL1β Is independently correlated with IL10 concentration
We next performed multiple linear regression analysis to
predict variants that were independently associated with
IL10 concentration. Thus, serum IL10 was entered as
dependent variable. The independent covariates included
anthropometry indices (% body fat, BMI, waist circum-
ference), blood glucose and lipid profile (SBP/DBP, totalcholesterol, TG, HDL, LDL, fasting insulin, fasting glu-
cose, HOMA-IR index), iron parameters (serum iron,
serum TIBC, serum ferritin, transferrin saturation,
hepcidin) and pro-inflammatory cytokines (IL1β, TNFα,
IFNγ, NO). The initial linear regression analysis showed
no correlation between IL10 concentration and anthro-
pometry indices, fasting blood glucose, and lipid profiles.
Therefore, only iron parameters (serum iron, serum
TIBC, serum ferritin, transferrin saturation, hepcidin)
and pro-inflammatory cytokines (IL1β, TNFα, IFNγ,
NO) were selected for multivariate analyses.
IL1β was independently associated with IL10 (β=−0.157,
p<0.0001), after adjusting for gender, serum TIBC, transfer-
rin saturation, NO, TNFα, IFNγ and NO (Table 4; pooled,
Multivariate model: B). When overweight/obese adolescents
were assessed separately from normal weight, only IL1β
was inversely associated with serum IL10 (β=−0.231,
p=0.0009) (Table 4; overweight and obese, Model D). The
association between IL10 and IL1β became weaker in ado-
lescents with normal weight (β=−0.157, p=0.0002), after fur-
ther controlling for gender, NO, TNFα, IFNγ and NO
(Table 4; pooled, Multivariate model: C). The relationship
between IL10 and IL1β appears to differ in the normal
Table 2 Clinical and biochemical characteristics of children according to nutritional status
Normal Overweight Obese Ordinary
Medium IQR Medium IQR Medium IQR P-trend
Number (boys/girls) 231 (122/109) 44 (24/20) 50 (29/21)
Height¤ (cm) 155.51 7.33 156.62 6.84 159.64## 6.55 0.0002
Weight¤ (kg) 44.67 6.68 57.38** 5.32 70.80## 9.59 <0.0001
Waist¤ (cm) 64.96 6.20 78.60** 5.87 87.07## 9.56 <0.0001
Body fat¤ (%) 18.57 5.56 26.51** 4.52 32.10## 7.45 <0.0001
Fasting glucose (mg/dL) 90.00 8.00 91.50 8.50 92.00# 11.00 0.0005
Fasting serum insulin 11.37 5.96 16.20** 6.19 28.44## 19.68 <0.0001
HOMA-IR 2.58 1.40 3.63** 1.50 6.50## 4.58 <0.0001
SBP (mmHg) 109.00 12.00 111.50 15.50 116.00## 11.00 <0.0001
DBP (mmHg) 62.00 11.00 61.00 10.00 66.00## 8.00 0.0065
HDL- cholesterol (mg/dL) 58.00 17.00 49.00** 14.00 42.50## 13.00 <0.0001
LDL- cholesterol (mg/dL) 88.00 29.00 92.50 36.50 88.50 24.00 0.6458
Total cholesterol (mg/dL) 158.00 37.00 160.50 47.00 151.00 33.00 0.1283
Triglyceride (mg/dL) 62.00 32.00 68.00 44.00 78.00## 51.00 <0.0001
Serum iron (ug/dL) 86.00 45.00 87.50 39.00 80.00 38.00 0.3875
Serum TIBC (ug/dL) 342.00 58.00 359.00 61.00 343.00 59.00 0.6752
Serum ferritin (ng/dL) 50.00 42.00 40.00 42.50 47.00 34.00 0.4136
Transferritin Saturation (%) 24.90 14.18 25.32 15.65 22.89 11.51 0.5224
Hepcidin (ng/ml) 123.19 22.02 107.26 25.80 120.07# 34.35 0.0062
TNFα (pg/ml) 16.69 10.37 21.42* 12.30 21.56 11.44 0.1982
IFNγ (pg/ml) 5.92 3.10 6.41 2.48 6.16 3.38 0.8630
IL10 (pg/ml) 9.87 3.69 8.13* 2.74 9.08 3.41 0.5265
IL1β (pg/ml) 0.90 0.41 1.15* 0.62 1.11## 0.75 0.0006
NO (uM) 6.13 5.74 9.54** 5.97 8.05 4.29 0.0606
Data are presented as median ± interquartile range (IQR).
¤ presented as mean ± standard error of mean (SEM).
#, * p<0.05. Statistically different versus normal weight children by t-test.
## ,** p<0.01. Statistically different versus normal weight children by t-test.
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from the first year junior high school, so there was very lit-
tle variation in age. The correlation between IL10 and IL1β
was similar between girls and boys (R2=0.110 v.s.
R2=0.0908) and between overweight/obese and normal
weight (R2=0.113 v.s. R2=0.0912). However, the correlation
between IL10 and IL1β in normal weight girls differed from
those of overweight/obese girls (R2=0.0858 v.s. R2=0.212;
respectively) and between normal weight and overweight/
obese boys (R2=0.0903 v.s. R2=0.0492; respectively)
(Figure 1). These data indicate that IL1β is independently
correlated with IL10 homeostasis and this association is
more pronounced in girls who are overweight or obese.
Discussion
In the present study, we confirmed that young adoles-
cents who are overweight and obese had decreased
circulating IL10 concentration and increased pro-
inflammatory cytokines TNFα, IL1β and NO. Our studyalso found that pro-inflammatory cytokine IL1β and
IL10 are independently associated. A decline in serum
IL10 concentration in overweight and obese adolescents
may further contribute to the IL1β-mediated inflamma-
tory environment associated with obesity. IL1β has been
associated with the destruction of the insulin-producing
beta cell [28]. Administration of neutralizing monoclonal
antibodies to IL1β improved glycemic control and beta
cell function in type 2 diabetic patients [29]. Our study
showed IL10 concentration was neither correlated with
blood glucose homeostasis variables nor blood lipid pro-
files. This is partially explained by the low prevalence
rate of MetS in the study subjects. IL10 plays a critical
role in limiting inflammation and a switch in anti- and
pro-inflammatory balance towards pro-inflammatory
state in overweight and obese adolescents may promote
the progression of normal glucose tolerance to insulin
resistance in adulthood [30]. The pathogenesis of type 2
diabetes is complex, involving the interaction of genetic
Table 3 Pearson’s rank correlation coefficient and partial r of log-transformed serum IL10 with selected
anthropometric, iron status, individual components of MetS and inflammatory indicators analyzed in all subjects
(n=325)
Model 1a Model 2b
r p value r p value
Gender −0.03064 0.5821
Log Body fat (%) 0.04426 0.4265 0.0396 0.4775
Log BMI(kg/m2) −0.06153 0.2687 −0.06149 0.2697
Log waist(cm) 0.08005 0.1499 0.08226 0.1396
Log Sytolic BP(mmHg) −0.00615 0.9125 −0.00621 0.9113
Log Diastolic BP(mmHg) 0.03219 0.5631 0.02999 0.5906
Log Total cholesterol(mg/dL) −0.05163 0.3535 −0.05337 0.3383
Log Triglyceride(mg/dL) −0.04992 0.3697 −0.05166 0.3540
Log HDL cholesterol (mg/dL) 0.04768 0.3915 0.04941 0.9285
Log LDL- cholesterol (mg/dL) −0.00157 0.9775 −0.00501 0.9285
Log Fasting serum insulin (μIU/ml) 0.02903 0.6021 0.02846 0.6097
Log Fasting glucose (mg/dL) 0.04581 0.4105 0.04758 0.3933
HOMA-IR 0.03339 0.5487 0.03309 0.5528
Log Serum iron(ug/dL) 0.09526 0.0864 0.0955 0.0861
Log Serum TIBC(ug/dL) −0.13754 0.0131 −0.13789 0.0130
Log Serum ferritin(ng/ml) −0.02723 0.3535 −0.02548 0.6477
Log Transferrin Saturation 0.13037 0.0131 0.1307 0.0186
Log Hepcidin (ng/ml) 0.26157 <0.0001 0.27054 <0.0001
Log IL1β (pg/ml) −0.32945 <0.0001 −0.32826 <0.0001
Log TNFα (pg/ml) −0.21078 0.0001 −0.20954 0.0001
Log IFNγ(pg/ml) −0.14038 0.0113 −0.13892 0.0123
Log NO (μM) −0.285 <0.0001 −0.28661 <0.0001
Log GOT (IU/L) 0.03548 0.5239 0.04253 0.4455
Log GPT (IU/L) −0.09192 0.0981 −0.08804 0.1137
a Model1: Crude.
b Model2: Adjusted for gender.
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follow up study on obese children and adolescents is
needed to clarify the role of IL10 in the progression of
type 2 diabetes and MetS.
The association between IL10 and IL1β was more pro-
nounced in girls who are overweight or obese. Both
overweight/obese boys and girls had elevated serum
IL1β concentrations. However, correlations between
IL10 and IL1β concentrations were greater in over-
weight/obese girls (R2=0.212) than boys (R2=0.049).
Corcoran et al. investigated the effect of estrogen and
testosterone on the expression of pro-inflammatory me-
diators in macrophages obtained from patients with
coronary heart disease [31]. The authors showed testos-
terone reduced the expression of TNFα and IL1β; by
contrast, estrogen did not have these adverse effects
[31]. In our study, serum IL1β concentrations were simi-
larly increased in both overweight/obese boys and girls.This suggests that the difference between the two groups
is less likely to be explained by the effect of sex hor-
mones on IL1β. Adipose tissues derived adiponectin is a
potential mediator of IL10 [32]. Adiponectin concentra-
tions are inversely correlated with waist circumference,
BMI and total body fat [33]. We found that overweight/
obese boys had slightly higher waist circumference than
overweight/obese girls (84.7±3.2 cm v.s. 81.1±2.7 cm;
p=0.06). Although it did not reach statistical significance,
overweight/obese boys had slightly lower IL10 concen-
trations when compared with overweight/obese girls.
This contributed to a lower ratio of IL10/ IL1β in over-
weight/obese boys than girls (8.77±0.65 v.s. 9.93±0.86;
p=0.35). We hypothesize that adiponectin concentra-
tions may contribute to the gender difference in IL10
and IL1β association in overweight/obese adolescents.
Interleukins (ILs) are key mediators of the innate im-
mune response and inflammatory process. So far, 11
Table 4 Linear regression analyses of predictors of serum IL10 in young adolescents
Crude Model A* Multivariate model (B)#
Pooled (n=325) β p-value β p-value β p-value
Log Serum iron(ug/dL) 0.06702 0.0864 0.06716 0.0861
Log Serum TIBC(ug/dL) −0.30981 0.0131 −0.31047 0.013 −0.1578 0.2026
Log Serum ferritin(ng/ml) −0.01122 0.6248 −0.01051 0.6477
Log Transferrin Saturation (%) 0.08652 0.0187 0.08670 0.0186 0.04459 0.21111
Log Hepcidin (ng/ml) −0.1275 0.0478 −0.13164 0.0502
Log IL1β (pg/ml) −0.21868 <0.0001 −0.21834 <0.0001 −0.1568 <0.0001
Log TNF (pg/ml) −0.15167 0.0001 −0.15092 0.0001 −0.08206 0.0317
Log IFNγ (pg/ml) −0.12521 0.0113 −0.12405 0.0123 −0.11378 0.0124
Log NO (μM) −0.12417 <0.0001 −0.12491 <0.0001 −0.08628 0.0002
Normal weight (n=231) Crude Model A* Multivariate model (C)※
β p-value β p-value β p-value
Log Serum iron(ug/dL) 0.05598 0.2483 0.05604 0.2487
Log Serum TIBC(ug/dL) −0.29762 0.0665 −0.29704 0.0676
Log Serum ferritin(ng/ml) −0.02808 0.3080 −0.02826 0.3061
Log Transferrin Saturation (%) 0.07590 0.1022 0.07590 0.1029
Log Hepcidin (ng/ml) −0.19145 0.3327 −0.23717 0.2584
Log IL1β (pg/ml) −0.20687 <0.0001 −0.20810 <0.0001 −0.1572 0.0002
Log TNF (pg/ml) −0.16167 0.0007 −0.16165 0.0008 −0.0829 0.07
Log IFNγ (pg/ml) −0.13909 0.0178 −0.13939 0.0178 −0.10408 0.0548
Log NO (μM) −0.14744 <0.0001 −0.14735 <0.0001 −0.10764 0.0002
Overweight and obese (n=94) Crude Model A* Model D§
β p-value β p-value β p-value
Log Serum iron(ug/dL) 0.08013 0.2147
Log Serum TIBC(ug/dL) −0.31443 0.0932
Log Serum ferritin(ng/ml) 0.03041 0.4575 0.04130 0.3155
Log Transferrin Saturation (%) 0.09707 0.0975 0.10025 0.0848
Log Hepcidin (ng/ml) −0.08019 0.2256 −0.06115 0.3845
Log IL1β (pg/ml) −0.23952 0.0005 −0.23111 0.0009 −0.23111 0.0009
Log TNF (pg/ml) −0.09581 0.1846 −0.07848 0.2831
Log IFNγ (pg/ml) −0.07007 0.4424 −0.04873 0.5962
Log NO (μM) −0.04679 0.2784 −0.05602 0.1944
*Model A: Adjusted for gender.
#Model B: Multivariate model adding gender.
※Model C: Multivariate model adding gender.
§Model D: Adjusted for gender.
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ing IL1α, IL1β and IL1 receptor antagonist (IL1Ra) [28].
Circulating IL1β and IL1Ra are elevated in patients with
obesity and type 2 diabetes [34]. Short-term IL1α treat-
ment transiently causes insulin resistance at insulin re-
ceptor substrate 1 level in 3T3L1 adipocytes [35]. IL1Ra
is regarded as anti-inflammatory cytokine but it does not
directly elicit an anti-inflammatory response. It binds
tightly to IL1α and IL1β receptor on the cell surface,
hence blocking the activity of either IL1α or IL1β. A re-
cent report showed 13 weeks of IL1Ra therapy improvedglycemic control and the function of the insulin-
producing beta cell in patients with type 2 diabetes [34].
In this study, we also observed a positive relationship
between IL10 and iron status. Associations between
obesity and poor iron status have recently been de-
scribed in White and Hispanic children [36,37]. How-
ever, we found no difference in iron status between
normal body weight and overweight/obese adolescents
(data not shown). The relationship between IL10 and
iron metabolism is poorly understood. Patients with
Crohn’s disease receiving higher doses of IL10 developed
Figure 1 Correlation between IL10 and IL1β stratified by gender and BMI in 340 subjects (182 boys and 158 girls). Pearson’s correlation
coefficient correlation between IL10 and IL1β in normal weight boys (A), overweight/obese boys (B), normal weight girls (C) and (D)
overweight/obese girls.
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http://www.biomedcentral.com/1471-2431/13/123anemia and a dose-dependent increase of serum fer-
ritin concentration [19]. The authors suggested that
hyperferritinemia may result from direct stimulation of
ferritin translation by IL10 via the suppression of the
binding affinity of iron regulatory proteins to the 5’-un-
translated region of ferritin mRNA in human monocytic
cells [19]. Macrophages play a key role in the iron
homeostasis. Through erythrophagocytosis of senescent
red blood cells, macrophages recycle and redistribute
heme iron to the plasma. Chau et al. showed IL10 trig-
gers expression of heme oxygenase 1 (HO-1) via the p38
MAPK pathway and IL10-HO1 pathways are critical for
the protection against LPS-induced septic shock in mice
[38]. These data suggest that abnormal high concentra-
tion of IL10 may limit iron bioavailability to erythroid
progenitor cells; whilst, defective IL10 production may
impair HO1 mediated anti-inflammatory and anti-
oxidant responses. Nevertheless, the consequences of
defective IL10 synthesis and erythrogenesis in over-
weight and obese adolescents need to be further investi-
gated in a longitudinal study.
There are several limitations in our study. The cross-
sectional nature of the current study and the relative
small sample size are one of the limitations. Further, the
inverse correlation between serum IL10 and pro-
inflammatory cytokines may be casual and related to
IL10 polymorphisms. IL-10 secretion is tightly con-
trolled and under a stringent genetic regulation with75% of heritability [39]. The three polymorphisms -
1082G/A, -819C/T, and -592C/A in the IL10 promoter
region were reported to influence IL10 transcription. A
promoter polymorphism (−592C/A) was associated with
lower circulating IL-10 levels and an increased risk for
obesity and insulin resistance in Italian people [40].
However, this association was not confirmed in the
Chinese population [41]. Another limitation is that we
could not confirm which IL10-producing cells are af-
fected in obese children.
Conclusions
In conclusion, given the increasing numbers of obese
children in the population, it is critical to investigate the
factors associated with the obesity-related declines in
health. Our study confirmed that low IL10 concentration
is associated with overweight and obesity in young ado-
lescents. A decline in serum IL10 concentration in over-
weight and obese adolescents may further contribute to
the IL1β-mediated inflammatory environment associated
with obesity.
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